Sign Up to like & get
recommendations!
0
Published in 2018 at "Leukemia research"
DOI: 10.1016/j.leukres.2018.03.010
Abstract: BACKGROUND AND OBJECTIVE The standardization of treatment of older adults with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL) is challenging, especially in the age range of 55-65 years. This study aimed to compare intensive,…
read more here.
Keywords:
pediatric inspired;
chromosome negative;
negative acute;
philadelphia chromosome ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-019-0585-2
Abstract: Although cytogenetic abnormalities at diagnosis are recognized as an important prognostic factor in patients with Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (ALL), the prognostic impact has not been evaluated in allogeneic stem cell transplant (allo-SCT)…
read more here.
Keywords:
cytogenetic abnormalities;
group;
patients philadelphia;
philadelphia chromosome ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-116728
Abstract: Introduction: Myeloproliferative Neoplasms (MPNs) represents a disorder that involves abnormal proliferation of cells originating from the myeloid line. The proliferation of these cells can lead to complications that are at times fatal. Despite its potential…
read more here.
Keywords:
pmf;
epidemiology;
classical philadelphia;
philadelphia chromosome ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Haematologica"
DOI: 10.3324/haematol.2017.178988
Abstract: Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms (MPN) [essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF)] vary in morphological features, disease presentation, and, most importantly, clinical outcome.[1][1] The World Health Organization (WHO)
read more here.
Keywords:
negative myeloproliferative;
jak2 calr;
philadelphia chromosome;
myeloproliferative neoplasms ... See more keywords